Zila Retains William Blair & Company as Its Financial Advisor

  
    
  
  
    
      Zila, Inc. (NASDAQ:ZILAD) today announced that it has retained 
      investment bank William Blair & Company to assist it in exploring 
      strategic business opportunities.
    
    
      “In recent months, we have established a solid 
      foundation upon which to grow our business by reducing expenses, 
      restructuring our operations and adding new international markets for 
      ViziLite® Plus,” 
      said David Bethune, chairman and chief executive officer of Zila. “The 
      engagement of William Blair is an important element in our plan to shore 
      up our capital structure and further evaluate opportunities for growth.”
    
    
      About Zila, Inc.
    
    
      Zila, Inc., is a fully integrated oral diagnostic company dedicated to 
      the prevention, detection and treatment of oral cancer and periodontal 
      disease. ViziLite® 
      Plus with TBlue®, the 
      company's flagship product for the early detection of oral abnormalities 
      that could lead to cancer, is the first and only adjunctive medical 
      device cleared by the FDA for use in a population at increased risk for 
      oral cancer. In addition, Zila designs, manufactures and markets a suite 
      of proprietary products sold exclusively and directly to dental 
      professionals for periodontal disease, including the Rotadent® 
      Professional Powered Brush, the Pro-Select Platinum® 
      ultrasonic scaler and a portfolio of oral pharmaceutical products for 
      both in-office and home-care use.
    
    
      This press release contains forward-looking statements within the 
      meaning of Section 27A of the Securities Act of 1933 and Section 21E of 
      the Securities Exchange Act of 1934. These forward-looking 
      statements are based largely on Zila's expectations or forecasts of 
      future events, can be affected by inaccurate assumptions and are subject 
      to various business risks and known and unknown uncertainties, a number 
      of which are beyond the Company's control. Therefore, actual 
      results could differ materially from the forward-looking statements 
      contained herein. A wide variety of factors could cause or 
      contribute to such differences and could adversely affect revenue, 
      profitability, cash flows and capital needs. There can be no 
      assurance that the forward-looking statements contained in this press 
      release will, in fact, transpire or prove to be accurate. For a 
      more detailed description of these and other cautionary factors that may 
      affect Zila's future results, please refer to Zila's Form 10-K for its 
      fiscal year ended July 31, 2007 and Form 10-Q for the quarter ended 
      April 30, 2008.
    
    
      For more information about the company and its products, please visit www.zila.com.